Abstract:Panax notoginseng flower saponins (PNFS) are great contributions towards the biological activity of Panax notoginseng flower (PNF). However, some ginsenoside monomers can be hydrolyzed by the acidic environment in the stomach, resulting in a decrease in their oral bioavailability. Therefore, we created PNFS enteric-coated sustained-release pellets (E-PNFS) to improve their oral bioavailability.The PNFS uncoated pellets (N-PNFS) and E-PNFS were prepared by fluidized bed coating technology using Eudragit NE30D as the sustained-release agent and Opadry as the enteric-coated agent. The single-factor investigation was used to determine the optimal prescription. The E-PNFS were visualized by scanning electron microscopy (SEM) and evaluated for roundness, bulk density, resting angle, hygroscopicity and stability. The plasma drug concentration in SD rats was determined by the UPLC-MS/MS method, and pharmacokinetic parameters were calculated by Phoenix WinNonlin5.2 software. The in vivo absorption fraction was calculated by Wagner-Nelson method The in vivo absorption and in vitro release percentages were linearly regressed by the least square method.According to the prescription screened out by the single factor investigation, E-PNFS was successfully prepared, and had good release properties in vitro along with a good measure for roundness, flowability and stability. Compared with N-PNFS, E-PNFS showed decreased Cmax, increased AUC, and an extended MRT and Tmax. Rb1, Rb2, Rb3 and Rc in E-PNFS showed a good correlation between in vitro release and in vivo absorption.The successfully prepared E-PNFS were able to improve the oral bioavailability of PNFS in SD rats in general. The in vitro release behaviors of Rb1, Rb2, Rb3 and Rc in E-PNFS correlated well with the in vivo absorption properties.<ol class="links-for-figure"><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1773224721000022-fx1_lrg.jpg">Download : Download high-res image (187KB)</a></li><li><a class="anchor download-link u-font-sans" href="https://ars.els-cdn.com/content/image/1-s2.0-S1773224721000022-fx1.jpg">Download : Download full-size image</a></li></ol>

Preparation and in vitro release of sustained-release matrix pellets of norcantharidin

3D Printing and Coating to Fabricate a Hollow Bullet-Shaped Implant with Porous Surface for Controlled Cytoxan Release

Preparation of Sustained Release Capsules by Electrostatic Dry Powder Coating, Using Traditional Dip Coating As Reference

Pharmacokinetics, Tissue Distribution, and Metabolites of a Polyvinylpyrrolidone-Coated Norcantharidin Chitosan Nanoparticle Formulation in Rats and Mice, Using LC-MS/MS

Solid Self-Nanoemulsifying Cyclosporin A Pellets Prepared by Fluid-Bed Coating: Preparation, Characterization and in Vitro Redispersibility

Preparation and characterization of norcantharidin liposomes modified with stearyl glycyrrhetinate.

[Preparation and in Vitro Evaluation of Tanshinone IIA Pulsatile Release Pellets].

Preclinical evaluations of Norcantharidin liposome and emulsion hybrid delivery system with improved encapsulation efficiency and enhanced antitumor activity

Solid Self-Nanoemulsifying Cyclosporine A Pellets Prepared by Fluid-Bed Coating: Stability and Bioavailability Study

Study on the Physicochemical Properties and the Intestinal Absorption Kinetics of Norcantharidin in Rats

Preparation of Panax notoginseng flower saponins enteric-coated sustained-release pellets and its pharmacokinetics and in vitro-in vivo correlation

Liposomal Nanodrug Based on Norcantharidin Derivative for Increased in Vivo Activity

Preparation and evaluation on sustained-release pellets containing total lactones of Ginkgo biloba

Understanding the release performance of pellets with hydrophobic inclusions in sustained-release coating

Strategies for Solubility and Bioavailability Enhancement and Toxicity Reduction of Norcantharidin

A nanofiber-based drug depot with high drug loading for sustained release

Chitosan-modified mesoporous silica nanoparticles for the oral delivery of Norcantharidin: In vitro and in vivo assessment

Preparation and Characterization of 10-Hydroxycamptothecin Loaded Nanostructured Lipid Carriers

Preparation and in vitro evaluation of a novel combined multiparticulate delayed-onset sustained-release formulation of diltiazem hydrochloride

Diagnostic yield of positive immunochemical occult-blood test by digital rectal examination: comparison between subjects with and without haemorrhoids.

Characterization and In vitro Release & In vivo Behavior Study of Self-Assembled Nano-Emulsion in XiaoYao Pill for Enhanced Drug Delivery